PharmaVoice 100: Page 4
-
Profile // PharmaVoice 100
DE&I Champions: Jennifer Gottlieb
The global president and chief client officer of Real Chemistry is dedicated to ensuring all voices at the agency are heard and everyone has a seat at the table.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Jennifer Gould
How the director of marketing excellence at GSK is helping usher in a new era of pharma marketing and patient personalization with a collaborative cross-industry approach.
By Karissa Waddick • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Jennifer Kelly
The president of patient experience is helping transform clinical trials with an innovative platform.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Dr. Jeremy Levin
Over his 30-year career, the founder, chairman and CEO of Ovid Therapeutics has demonstrated that he is a patient advocate, scientist, clinician and innovator at heart.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Jim Anthony
With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Jim Doherty
Sage Therapeutics’ chief development officer is leveraging innovative development strategies to create success against hard-to-treat brain disorders.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: John Oyler
The CEO of BeiGene is using innovative business strategies to help the oncology biotech quickly hit new heights.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Dr. John Tsai
How the former president of global drug development and chief medical officer at Novartis funneled his curiosity for engineering into a bold new approach to drug development.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Johnna Wesley
The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Dr. Jonathan Ng
As CEO of Iterative Scopes, Dr. Jonathan Ng is relentlessly committed to health equity while leveraging AI to establish new standards of care for detection and treatment of GI diseases.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Jonathan Steckbeck
The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Dr. Jordan Schecter
The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Julie Kim
The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.
By Michael Gibney • Sept. 6, 2022 -
Profile // PharmaVoice 100
Innovators: Karin Jooss
The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Kathy Lee-Sepsick
Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Dr. Kerry Blanchard
The former CEO of Everest Medicines has focused on breaking new ground for China-based innovation.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Legacy Leaders: Kim Johnson
The Global CEO is breathing fresh air into Ogilvy Health as she blazes a new trail at the storied agency.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Kuldeep Singh Rajput
Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.
By Michael Gibney • Sept. 6, 2022 -
Profile // PharmaVoice 100
Tech Wizards: Kunal Ghosh
The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: LaQuinta Jernigan
The chief operating officer and ‘face’ of mdgroup is a leading voice in the efforts to diversify clinical trials.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Dr. Laura Niklason
The founder, president and CEO of Humacyte is turning science fiction into regenerative medicine reality.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Laurent Levy
Nanobiotix’s co-founder is applying the principles of nanophysics to fight cancer with a universal mechanism of action.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Laxmi Bonagiri
EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Lisa Walters-Hoffert
Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
DE&I Champions: Lori Abrams
The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.
By PharmaVoice staff • Sept. 6, 2022